zirconium has been researched along with 3,4-diaminocyclobut-3-ene-1,2-dione in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cullinane, C; Donnelly, PS; Haskali, MB; Hicks, RJ; Noor, A; Roselt, PD; Rudd, SE; Van Zuylekom, JK; Waldeck, K; Wheatcroft, MP; Yan, E | 1 |
| Cullinane, C; Donnelly, PS; Haskali, MB; Hicks, RJ; Noor, A; Roselt, PD; Rudd, SE; Van Zuylekom, JK; Wheatcroft, M; Yan, E | 1 |
2 other study(ies) available for zirconium and 3,4-diaminocyclobut-3-ene-1,2-dione
| Article | Year |
|---|---|
Bivalent Inhibitors of Prostate-Specific Membrane Antigen Conjugated to Desferrioxamine B Squaramide Labeled with Zirconium-89 or Gallium-68 for Diagnostic Imaging of Prostate Cancer.
Topics: Animals; Antigens, Surface; Cell Line, Tumor; Cell Transformation, Neoplastic; Deferoxamine; Enzyme Inhibitors; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Isotope Labeling; Male; Mice; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Quinine; Radioisotopes; Tissue Distribution; Zirconium | 2020 |
Imaging Somatostatin Positive Tumors with Tyr
Topics: Animals; Deferoxamine; Gallium Radioisotopes; Mice; Octreotide; Quinine; Radioisotopes; Somatostatin; Zirconium | 2021 |